Expert Breast Cancer Treatment Recommendations Based on Latest Evidence Updating for Multiple Languages

National Comprehensive Cancer Network  

PR85917

 

PLYMOUTH MEETING, Pennsylvania, Oct. 5, 2020 /PRNewswire=KYODO JBN/ --

 

--Ongoing updates are underway for NCCN Guidelines for Breast Cancer in

Chinese, English, French, Japanese, Korean, Spanish, Polish, and Portuguese,

free online at NCCN.org/global (https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=1922784669&u=http%3A%2F%2Fwww.nccn.org%2Fglobal&a=NCCN.org%2Fglobal ).

Follow #NCCNGlobal (https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=3670714091&u=https%3A%2F%2Ftwitter.com%2Fsearch%3Fq%3D%2523NCCNGlobal%26src%3Dtyped_query%26f%3Dlive&a=%23NCCNGlobal ) for more.

 

--NCCN Foundation is hosting free metastatic breast cancer webinars for

patients and caregivers on October 8 and 12 at NCCN.org/patients

(https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=2281405580&u=https%3A%2F%2Fwww.nccn.org%2Fpatients%2Fresources%2Fbreast-cancer-2020.aspx&a=NCCN.org%2Fpatients ).

 

During Breast Cancer Awareness Month this October, the National Comprehensive

Cancer Network(R) (NCCN (https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=3584390045&u=http%3A%2F%2Fwww.nccn.org%2F&a=NCCN )(R)) is sharing

and updating evidence- and expert consensus-based management recommendations

which lead to optimal outcomes for people with breast cancer.1 Translations of

the English-language NCCN Guidelines (https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=4286414893&u=https%3A%2F%2Fwww.nccn.org%2Fprofessionals%2Fdefault.aspx&a=NCCN+Guidelines )(R) for Breast Cancer (https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=331602302&u=https%3A%2F%2Fwww.nccn.org%2Fprofessionals%2Fphysician_gls%2Fdefault.aspx%23breast&a=Breast+Cancer ) have recently been updated in Chinese, Japanese,

and Spanish. The currently-available Korean, French, Polish, and Portuguese versions will

be updated by the end of the month. All are free at NCCN.org/global (https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=3430697588&u=https%3A%2F%2Fwww.nccn.org%2Fglobal%2Finternational_adaptations.aspx%23translations&a=NCCN.org%2Fglobal ).

 

Photo -

https://mma.prnewswire.com/media/1306011/NCCN_Breast_Cancer_Guidelines_Translations.jpg 

 

Logo - https://mma.prnewswire.com/media/441768/NCCN_Logo.jpg 

 

"Breast cancer has a very high cure rate, but remains the most common cancer

and the leading cause of cancer-related death for women worldwide," said Robert

W. Carlson, MD, Chief Executive Officer, NCCN and Professor of Medicine

(Emeritus), Stanford University Medical Center, who specialized in breast

cancer. "We want health care providers everywhere to have access to the

carefully-vetted treatment recommendations included in the NCCN Guidelines.

That's why we're always looking for ways to increase the readability and

accessibility of these resources."

 

NCCN also adapts NCCN Guidelines into tiered and pragmatic approaches for

varying resource availability in low- and middle-income countries, called the

NCCN Framework for Resource Stratification of NCCN Guidelines (NCCN Framework

(https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=243247110&u=https%3A%2F%2Fwww.nccn.org%2Fframework%2Fdefault.aspx&a=NCCN+Framework )(TM)). There are also International Adaptations (https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=1717249067&u=https%3A%2F%2Fwww.nccn.org%2Fglobal%2Finternational_adaptations.aspx&a=International+Adaptations ) of the NCCN Guidelines for Breast Cancer for

the Middle East and North Africa (MENA) region and Spain, as well as NCCN

Harmonized Guidelines (https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=3863714990&u=https%3A%2F%2Fwww.nccn.org%2Fharmonized%2Fdefault.aspx&a=Harmonized+Guidelines )(TM) for Sub-Saharan Africa and the Caribbean, all written in collaboration

with regional oncology experts.

 

The NCCN Guidelines for Breast Cancer have also served as the basis for

creation of three volumes of NCCN Guidelines for Patients (https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=593607461&u=https%3A%2F%2Fwww.nccn.org%2Fpatients%2Fguidelines%2Fcancers.aspx%23breast&a=NCCN+Guidelines+for+Patients )(R), to help cancer patients talk with

their physicians about the best treatment options for Ductal Carcinoma in Situ (DCIS),

Invasive Breast Cancer, and Metastatic Breast Cancer.

 

"We are expanding our knowledge of this disease at a rapid pace," said William

J. Gradishar, MD, Robert H. Lurie Comprehensive Cancer Center of Northwestern

University (https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=4260489204&u=https%3A%2F%2Fwww.cancer.northwestern.edu%2F&a=Robert+H.+Lurie+Comprehensive+Cancer+Center+of+Northwestern+University ), Chair, NCCN Guidelines

Panel for Breast Cancer. "We've made six updates to the main breast cancer guidelines

already this year. They include multiple new treatment recommendations covering

management, staging, and special circumstances such as pregnancy."

 

NCCN also has separate guidelines on topics like screening (https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=2786673541&u=https%3A%2F%2Fwww.nccn.org%2Fprofessionals%2Fphysician_gls%2Fdefault.aspx%23breast_screening&a=screening ), genetic/familial risk assessment

(https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=259873968&u=https%3A%2F%2Fwww.nccn.org%2Fprofessionals%2Fphysician_gls%2Fdefault.aspx%23genetics_screening&a=genetic%2Ffamilial+risk+assessment ),

risk reduction (https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=1302014153&u=https%3A%2F%2Fwww.nccn.org%2Fprofessionals%2Fphysician_gls%2Fdefault.aspx%23breast_risk&a=risk+reduction ), and supportive care (https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=1402711673&u=https%3A%2F%2Fwww.nccn.org%2Fprofessionals%2Fphysician_gls%2Fdefault.aspx%23supportive&a=supportive+care ).

 

The NCCN Guidelines for Breast Cancer were downloaded more than 890,000 times

in 2019, making it the most-downloaded NCCN guideline across all cancer types.

At least 335,000 of those downloads came from outside the United States,

including more than 36,000 from Spain and Mexico, 31,000 from China, and 21,000

from Brazil. The non-English versions were downloaded more than 4,000 times.

 

Visit NCCN.org/global (https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=1922784669&u=http%3A%2F%2Fwww.nccn.org%2Fglobal&a=NCCN.org%2Fglobal )

to learn more about all of the available cancer resources, and join the

conversation with the hashtag #NCCNGlobal (https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=3670714091&u=https%3A%2F%2Ftwitter.com%2Fsearch%3Fq%3D%2523NCCNGlobal%26src%3Dtyped_query%26f%3Dlive&a=%23NCCNGlobal ).

 

Free Breast Cancer Patient Webinars

The NCCN Foundation (https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=1527897431&u=https%3A%2F%2Fwww.nccn.org%2Fpatients%2Ffoundation%2Fdefault.aspx&a=NCCN+Foundation )(R) is hosting two free patient webinars about metastatic

breast cancer on October 8 (https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=167798350&u=https%3A%2F%2Fnccn.webex.com%2Fnccn%2Fonstage%2Fg.php%3FMTID%3De05672800f6dc1b47eaaff34559cf0407&a=8 ) and 12 (https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=1290350781&u=https%3A%2F%2Fnccn.webex.com%2Fnccn%2Fonstage%2Fg.php%3FMTID%3De2dd47c432f0e7c353e5e5e3b9fa6c2d1&a=12 ), 2020, based on the NCCN Guidelines for Patients.

 

Visit nccn.org/patients/resources/breast-cancer-2020.aspx (https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=2554640993&u=https%3A%2F%2Fwww.nccn.org%2Fpatients%2Fresources%2Fbreast-cancer-2020.aspx&a=nccn.org%2Fpatients%2Fresources%2Fbreast-cancer-2020.aspx )

for more information and registration.

 

About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network(R) (NCCN (https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=3584390045&u=http%3A%2F%2Fwww.nccn.org%2F&a=NCCN )(R))

is a not-for-profit alliance of leading cancer centers (https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=1399039089&u=https%3A%2F%2Fwww.nccn.org%2Fmembers%2Fnetwork.aspx&a=leading+cancer+centers ) devoted to patient care, research, and education. NCCN is dedicated to

improving and facilitating quality, effective, efficient, and accessible cancer

care so patients can live better lives. The NCCN Clinical Practice Guidelines

in Oncology (NCCN Guidelines (https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=4286414893&u=https%3A%2F%2Fwww.nccn.org%2Fprofessionals%2Fdefault.aspx&a=NCCN+Guidelines )(R)) provide transparent, evidence-based, expert consensus recommendations for

cancer treatment, prevention, and supportive services; they are the recognized

standard for clinical direction and policy in cancer management and the most

thorough and frequently-updated clinical practice guidelines available in any

area of medicine. The NCCN Guidelines for Patients (https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=2135832043&u=https%3A%2F%2Fwww.nccn.org%2Fpatients%2Fguidelines%2Fcancers.aspx&a=NCCN+Guidelines+for+Patients )(R) provide expert cancer treatment information

to inform and empower patients and caregivers, through support from the NCCN

Foundation (https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=1634497900&u=https%3A%2F%2Fwww.nccn.org%2Fpatients%2Fwaystogive%2Fdefault.aspx&a=NCCN+Foundation )(R). NCCN also advances continuing education (https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=3465003812&u=https%3A%2F%2Feducation.nccn.org%2F&a=continuing+education ),

global initiatives (https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=3970539329&u=https%3A%2F%2Fwww.nccn.org%2Fglobal%2Fdefault.aspx&a=global+initiatives ),

policy (https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=23804482&u=https%3A%2F%2Fwww.nccn.org%2Fprofessionals%2Fmeetings%2Foncology_policy_program%2Fdefault.aspx&a=policy ), and research collaboration (https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=2077981111&u=https%3A%2F%2Fwww.nccn.org%2Fclinical_trials%2Fclinicians.aspx&a=collaboration ) and publication (https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=3126579684&u=https%3A%2F%2Fwww.nccn.org%2Fjnccn%2F&a=publication ) in oncology.

Visit https://NCCN.org  for more information and follow NCCN on

Facebook @NCCNorg (https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=4064464649&u=http%3A%2F%2Fwww.facebook.com%2FNCCNorg&a=%40NCCNorg ),

Instagram @NCCNorg (https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=1387959517&u=https%3A%2F%2Fwww.instagram.com%2Fnccnorg%2F&a=%40NCCNorg ),

and Twitter @NCCN (https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=787793643&u=http%3A%2F%2Fwww.twitter.com%2Fnccn&a=%40NCCN ).

                

1 Vaddepally. J Clin Oncol 36, suppl 30; abstr 47, 2018,

https://meetinglibrary.asco.org/record/166668/abstract .

 

Media Contact:

Rachel Darwin

+1 267-622-6624

darwin@nccn.org

 

SOURCE: National Comprehensive Cancer Network  

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中